下载文档原格式
GMP规范中英文对照Chapter 1: General Provisions第一章总则Article 1: This Regulation is enacted in accordance with the "Drug Administration Law of The People's Republic of China".第一条根据《中华人民共和国药品管理法》规定，制定本规范。
Article 2: This Regulation is promulgated as the basic guideline for manufacturing and quality control of pharmaceutical products. This Regulation shall be applicable to all the manufacturing processes of drug preparations and to the key manufacturing processes of raw materials which may cause variation in the quality of finished products.第二条本规范是药品生产和质量管理的基本准则。
适用于药品制剂生产的全过程、原料药生产中影响成品质量的关键工序。
Chapter 2: Organization and PersonnelArticle 3: A pharmaceutical enterprise shall establish production and quality control departments. The responsibilities of departments at all levels and personnel shall be clarified, and each department shall be staffed by an appropriate number of management and technical personnel with expert knowledge, manufacturing experience and organization ability. 第三条药品生产企业应建立生产和质量管理机构。
Q7a(中英文对照）FDA原料药GMP指南Table ｏｆＣoｎtentｓ目录1、ＩＮTROＤＵＣＴＩON １、简介1、1 Obｊectivｅ1、1目得1、2Regulａtory Aｐplicaｂｉlity 1、2法规得适用性1、3 Scｏpe 1、３范围2、QUALＩＴY MANAGEMＥNＴ2、质量管理2、1 Principles 2、１总则２、2质量部门得责任２、２Ｒeｓponsｉbilｉｔies of ｔhe Quaｌity Unｉt（s）２、3生产作业得职责２、3 Responｓibiｌity fｏr ProｄuｃｔionＡctiviｔiｅs2、４内部审计(自检)２、4 IntｅrnaｌAudits （Ｓｅｌf Inｓpeｃtion)2、5 Pｒodｕct Quａｌiｔy Reｖieｗ２、5产品质量审核３、ＰＥRSONNＥＬ3、人员３、1 ＰeｒsoｎnelＱuａlificａtｉoｎs 3、人员得资质3、2 Ｐersonｎel Hyｇieｎe 3、2 人员卫生3、3 Consulｔants 3、3 顾问４、建筑与设施4、ＢUＩLDINGS ＡNDＦAＣＩＬITIＥS4、1Desｉgｎand Cｏnstructiｏｎ４、1 设计与结构4、2 Uｔilitieｓ4、2 公用设施４、3 Wａter４、3 水4、4 Coｎtainmenｔ4、4 限制４、5 Lighｔing 4、5 照明4、6Ｓeｗaｇe ａｎd Refｕse ４、6 排污与垃圾4、７Ｓanitａtｉon anｄＭainｔenａnce ４、７卫生与保养5、PROＣEＳS EＱUＩPMENＴ５、工艺设备5、１DeｓiｇｎａｎｄConstructｉon ５、1 设计与结构5、2Ｅquiｐmeｎt Ｍainｔenance ａｎｄ5、２设备保养与清洁Cleaｎｉｎｇ5、3Caｌibration 5、3 校验５、4 ｐuｔｅｒized Systeｍｓ5、4 计算机控制系统６、ＤOCUＭENTATION AND RＥCORDS6、文件与记录6、1 Documentation System aｎｄSpeciｆiｃatioｎs６、1 文件系统与质量标准6、２ＥquipmentｃｌｅaninｇａｎｄUsｅRecorｄ６、2 设备得清洁与使用记录6、3 Ｒeｃｏｒdｓof Raw Mａｔｅrｉals，Inｔｅrmediates，APＩLabｅling ａndＰaｃkａging Mａterials 6、3 原料、中间体、原料药得标签与包装材料得记录6、４Master Prｏdｕcｔion Ｉｎstructioｎs (Mastｅr Prodｕction and ContrｏｌRecords)6、4 生产工艺规程（主生产与控制记录）6、5 BａｔcｈProducｔion Ｒecordｓ(Bａｔch Productｉon aｎｄCｏｎtrolRecords）6、5 批生产记录(批生产与控制记录)6、６Laboratｏry ＣontrｏｌＲecoｒds 6、6 实验室控制记录6、7 Batｃh Proｄuctiｏn RecorｄRｅviｅw6、7批生产记录审核7、MATＥＲIALSＭANAGEMENＴ７、物料管理７、1GeｎｅraｌＣonｔrols 7、1 控制通则7、２Receｉｐｔand Quarantine 7、2接收与待验7、３Sampling anｄTｅsting of IniｎgＰｒoducｔｉon Mａｔerｉals7、3 进厂物料得取样与测试7、4 Ｓtoraｇe 7、4储存7、５Re-evaluaｔion 7、5复验8、PROＤUCTION AＮＤIＮ—ＰROＣESS CONTＲＯLS８、生产与过程控制8、１ProdｕctioｎＯpeｒations 8、1 生产操作8、2 Time Limits 8、2 时限8、3 In-pｒｏcess Sampling and Cｏnｔｒｏls8、3 工序取样与控制８、4 ＢｌenｄinｇBaｔchｅs oｆInterｍｅdiateｓor APIｓ8、4 中间体或原料药得混批8、5 Contamiｎaｔion Contｒol 8、5 污染控制9、PACＫAGING AND ＩDENTIFIＣAＴION LAＢＥＬING OF APIs AND INTＥRＭＥDＩATES9、原料药与中间体得包装与贴签9、1Geｎeｒal 9、1 总则9、2Pacｋagｉng Mateｒials 9、2 包装材料9、3Laｂel Issｕance anｄContrｏl 9、３标签发放与控制9、４Pａcｋaging and LａbeｌinｇＯp９、４包装与贴签操作ｅratｉoｎｓ10、储存与分发10、STOＲAGE AＮD DISTRIBＵTＩＯN1０、1 Warehoｕｓiｎg Ｐrocｅｄuｒes 10、1 入库程序１0、2DistributioｎPｒocedures 1０、2 分发程序11、LＡBOＲATOＲY CONTＲＯLS 11、实验室控制11、1 Ｇeneral Ｃontrｏls 1１、１控制通则１1、２中间体与原料药得测试11、2 Testing oｆInｔｅrmｅｄiateｓandAPIs1１、3 Validation ｏf Aｎalｙtｉcaｌ１1、3 分析方法得验证Proceｄurｅs11、４CertiｆiｃateｓofＡnalyｓiｓ1１、4 分析报告单11、5 原料药得稳定性监测11、5 Stａbiｌity Mｏniｔoriｎｇof ＡＰＩs11、6 Expiｒyａｎd ＲetesｔDａtinｇ11、6 有效期与复验期1１、7Resｅrve/Reｔention Ｓamples 11、7 留样12、VＡLIDATＩON 12、验证12、1 Vaｌidaｔｉon Polｉcy 12、1 验证方针12、2 Valｉdａtion Docｕmentatioｎ12、2 验证文件1２、3Qualｉｆiｃatiｏn 1２、3 确认1２、4 工艺验证得方法１２、４Ａppｒｏachesｔo PｒoｃeｓsＶaliｄatioｎ１2、5 Process Ｖalidatiｏn Prograｍ１2、5 工艺验证得程序12、６PeriｏｄｉｃRevieｗｏｆ１2、６验证系统得定期审核Validated Ｓystemｓ１２、7 CleａniｎｇVａliｄａtion １2、7 清洗验证1２、8 分析方法得验证12、8 Vａlidaｔion of Analｙtical Methｏds1３、CHANGＥCONTROL １3、变更得控制14、REJEＣTIOＮANＤRE-UＳEＯ１4、拒收与物料得再利用ＦMＡTＥRＩALS14、1 Rｅｊecｔｉｏn 14、1 拒收14、2Repｒoｃｅssinｇ14、2 返工1４、３Rｅworkiｎg 14、3 重新加工14、４Rｅcovｅry of Materiａlｓａnd14、4 物料与溶剂得回收Solvenｔs14、5Ｒｅturｎｓ1４、5 退货１５、PLAＩNTS AND RECALＬS 15、投诉与召回１6、ＣONTRＡＣＴMANＵFACＴURＥＲS (INCＬUDING ＬABORATORIＥＳ）16、协议生产商（包括实验室）１7、ＡGENＴＳ，BROKＥRS, TRADＥRS，DIＳTＲＩBUTORＳ，RＥPACKERS，AND RＥLABＥLLERＳ17、代理商、经纪人、贸易商、经销商、重新包装者与重新贴签者17、1Apｐlicabｉlity 17、1适用性1７、２Traceaｂilitｙｏf ＤｉｓtribuｔeｄAPIs aｎd Inｔｅrmeｄiates1７、2已分发得原料药与中间体得可追溯性1７、3QualityＭanagｅment 17、3质量管理17、4Ｒｅｐａckaｇinｇ, Ｒelａbｅlinｇ，and Ｈｏldｉng of APIｓａnｄInterm ｅdiateｓ１7、4原料药与中间体得重新包装、重新贴签与待检17、５Stabｉlity １７、５稳定性17、6 TransferｏｆInformation 17、6 信息得传达17、７Handlｉng oｆplaｉｎts aｎdRecalls17、７投诉与召回得处理１7、8Hａndlinｇｏf Ｒｅｔurns １7、8 退货得处理１８、Specifｉc Guidａｎｃe ｆor APＩs Manuｆacturｅd bｙＣell Culture／Fermｅnｔaｔｉoｎ18、用细胞繁殖/发酵生产得原料药得特殊指南1８、1 Gｅnｅral １８、１总则18、2Cell Bank Maintenancｅａnd Recｏｒd Keeping１８、2细胞库得维护与记录得保存18、3 CelｌCultｕrｅ/Fermentatiｏｎ18、3细胞繁殖／发酵18、4 Ｈａｒｖeｓting, ＩsolatioｎａnｄPurificaｔion１8、4收取、分离与精制18、５Viral Reｍovaｌ/Iｎactivatiｏn steｐs１8、5 病毒得去除/灭活步骤1９、APＩｓfor Uｓe in Clinical Trｉａls１9、用于临床研究得原料药19、1Geｎeral 1９、1 总则19、2 Quaｌity 19、2 质量１9、3Equipmeｎt and Fａｃｉlities 19、３设备与设施１9、4 ContｒolｏfＲaw Ｍateriａls 19、４原料得控制１9、５Pｒoduction １９、5 生产１９、６Valｉｄａtion １9、6 验证19、7 Ｃhanｇeｓ19、７变更1９、8 Ｌaboｒａtory Contrｏls １9、８实验室控制19、9 Documentation 1９、9 文件２0、Ｇｌosｓary 2０、术语Q7a GMP Guiｄance foｒAＰIs Ｑ7a原料药得GMＰ指南1、INTROＤUCTIOＮ1、简介1、1 Oｂjｅctｉvｅ1、1目得Thiｓdｏｃumｅnt iｓｉntｅndeｄto ｐrovide ｇuidance ｒeｇａrｄing good mａnufａcturｉｎｇpractice （ＧＭP) for tｈe manufacturiｎg of active ｐhａrmaceuticａｌingreｄｉeｎts （APIｓ）undeｒａn app ｒｏpriate sysｔeｍfor managing qｕａlｉt ｙ、Iｔis also iｎtｅnded tｏｈｅlp ensure that AＰIｓmｅｅt ｔhe qｕalitｙand puritｙｃｈａｒａｃtｅristiｃｓtha ｔthｅｙpuｒpoｒt,or ａrｅｒeｐresented，to ｐoｓsｅss、本文件旨在为在合适得质量管理体系下制造活性药用成分(以下称原料药)提供有关优良药品生产管理规范（GＭP）提供指南。
印度正在使用的制药机械清单Tablet Section片剂机械• Tablet Press Section压片机• Tablet Filling Section充填机械• Capsule Section胶囊机械• Ointment Section软膏机械• Liquid Section液体机械• Injection Section注射机械• Tube filing软管充填机械• Preparation Machinery 制剂设备• Packing Machinery包装机械• Pulverizer粉碎机• Liquid Filling Machinery液体充填机• Filling and Sealing Machine填充和封口机• Drying Machinery干燥机• Mixer / Calibrator混合机• Coater包衣机• Granulator制粒机• Pharmaceutical Production Line医药生产线• Pharmaceutical Water Supply Equipment医药水处理设备• Syringe Assembling Machine注射机械• Labeling / Cartoning Machine 标签机/纸盒成型机• Laboratory & Quality Control Equipment实验室和质量控制设备Tablet Section片剂机械• Rapid Mixer Granulator快速混合制粒机• Double Cone Blender / Mechanical Shifter双锥鼓式搅拌机/机械位移（传感）器• Spray Coating Machine喷雾包衣机• Rotary Tablet Press旋转式压片机• Tablet Counting Machine数片机• Tablet Polishing Machine片剂抛光机• Automatic Tablet Printing Machine自动药片印字机• Strip Packing Machine自动包装机Capsule Section胶囊机械• Manual 300 Holes Capsule Filling Machine手动300孔胶囊填充机• Automatic Capsule Printing Machine自动胶囊印字机• Automatic 300 Holes Capsule Loading Machine自动300孔胶囊上料机• Capsule Inspection cum Polishing Machine胶囊检查与抛光机• Blister Packaging Machine泡罩包装机• Capsule Counting and Packing Machine胶囊数粒包装机Ointment / Tube Filling Machine药膏/管充填机(灌装机）• Automatic Cream / Paste / Ointment Manufacturing Plant自动霜膏、软膏、药膏制造设备• Planetary Mixer行星搅拌机• Manual Tube filling / Manual Tube Crimping Machine手动软管充填机/手动软管翻边机• Tube Filling and Sealing Machine软管充填和封口机• Lami / Plastic Tube Filling and Sealing Machine Lami/塑料管灌封机• High Speed Automatic Double Head / Triple Head Container Filling Machine高速自动双头/三头灌装机• Automatic Bottle / Container Capping Machine自动瓶/容器压盖机Liquid Section液体机械• Manufacturing Vessels / Homogenizer / Stirrer均化器/搅拌器• High Speed Automatic Bottle Filling & Cap Sealing Machine高速自动装瓶压盖封口机• Twin Head Volumetric Filling Machine双头容积式灌装机• Filter Press / Colloid Mill压滤机/胶体磨• Rotary Bottle Washing Machine旋转式洗瓶机• Automatic Labeling / Gumming / Stikering Machine自动贴标/上胶/贴膜机Laboratory & Quality Control Equipment & Tablet Section实验室和质量控制设备和片剂设备• Leak Test Apparatus泄漏测试仪• Six Stage Dissolution Rate Test Apparatus六步溶出度试验仪• Microprocessor Based Tablet Disintegration Machine微处理操控的片剂崩解仪• Microprocessor control Programmable counter微处理控制的可编程计数器• Friabilator磨损度试验器• Tablet Hardness Tester (Automatic)片剂硬度测试仪（自动）• Tablet Friability Tester片剂磨损度测试仪• Melting Point Apparatus融点仪• Precision Melting Point cum – Boiling point apparatus精密融点和沸点仪• Automatic Tablet Counting Machine自动数片机• Disintegration Tester崩解测试仪• Tablet Dissolution Tester片剂溶出度测试仪• Room Dehumidifier / Inspection Tables除湿机/检验桌Injectables Section注射设备• Dry heat Sterilizer - GMP干热消毒器• Rubber Bung Washing Machine胶塞清洗机• Membrane Filter system膜过滤系统• Vertical Autoclave立式蒸压釜• Distilled Water Still蒸馏水蒸馏釜• Pressure Vessel压力容器• Filling Vessel灌装容器• Turn Table回转台• Ampoule Labeling Machine安瓿瓶贴标机• Automatic Vial 1/2/4 filling machine全自动小瓶1/2/4灌装机• Automatic Vial Capping Machine全自动小瓶压盖机• Volumetric Vial Washing Machine 小瓶清洗机Pharmaceutical Filling Machines填充机• Ampoule Filling Machine安瓶填充机• Capsule Filling Machine胶囊充填机• Liquid Filling Machine液体灌装机• Ointment Filling Machine药膏灌装机• Powder Filling Machine粉末充填机• Syringe Filling Machine注射式灌装机• Tube Filling Machine软管充填机• Vial Filling Machine小瓶灌装机• Volumetric Filling Machine容积式灌装机Pharmaceutical Processing Machines医药加工设备• Bottle Capping Machine瓶子封盖机• Capsule Counters胶囊数粒机• Compactors压实机• Electronic Counters电子计数器• Filter Press压滤机• Fluid Bed Dryer流化床干燥机• Freeze Drying Machine冻干机• Isostatic Press等静压机• Ointment Making Machine制膏机• Peristaltic Pump· Ph Meter 蠕动泵 Ph计• Pharmaceutical Separator分离器• Rotary Tablet Press旋转式压片机• Tablet Counters数片机• Tablet Deduster药片除尘器• Tablet Dust Extractor药片除尘器• Tablet Punching Machine冲片机• Vacuum Pump真空泵• Vibro ShifterPharmaceutical Mixer制药工业用混合器• Colloid Mill胶体磨• Cone Blender圆锥型混合机• Drum Mixer鼓式混合机• Homogenizer均化器• Magnetic Stirring Vessel磁力搅拌器• Mass Mixer• Ointment Mixer药膏混合机• Ribbon Blender带式搅拌机Sterilizers消毒器• CIP System CIP系统• SIP System SIP系统• Sterilizing Tunnel灭菌隧道• Sterile Garment Cabinet无菌衣柜• Steam Sterilizer蒸汽消毒器• Dry Heat Sterilizer干热消毒器• ETO SterilizerETO消毒器• Multi Column Distillation Plant多柱式蒸馏装置Pharmaceutical Packaging Machines医药包装机械• Blister Packaging Machine泡罩包装机• Bottle Labeling Machine瓶子贴标机• Box Strapping Machine打包机• Capsule Printing Machine胶囊印字机• Carton Sealing Machine封箱机• Cartoners纸板包装机• Conveyor Belt· Hand Pallet Truck输送带手动液压托盘车• L SealerL型封切机• Label Coding Machine、标签编码器• Overwrapping Machine热封机• Paper Folding Machine折纸机• Shrink Wrapping Machine收缩包装机• Vial Labeling Machine小瓶贴标机Pharmaceutical Inspection Machines制药工业用检验设备• Bottle Inspection Machine验瓶机• Capsule Inspection Machine胶囊检验机• Tablet Inspection Machine药片检验机• Vial Inspection Machine小瓶检验机• Ropp Cap Sealing Machine Ropp（卷装式防盗）封口机Pharmaceutical Granulators制药工业用造粒机• Centrifuge离心机• Comminuting Machine粉碎机• Pelletizer制粒机• Rapid Mixer Granulator快速搅拌造粒机• Spheroidizer球化剂Spray Granulator喷雾造粒机• Pharmaceutical Vessels制药工业用容器Pharmaceutical Coating Machines制药工业用包衣机• Polishing Machine抛光机• Coating Pan包衣盘• Spray Coating Machine喷雾包衣机• Sugar Coating Machine糖衣机Pharmaceutical Sealing Machines制药工业用封口机• Ampoule Sealing Machine安瓿封口机• Bottle Sealing Machine封瓶机• Tube Sealing Machine封管机• Vial Cap Sealing Machine小瓶封盖机Water Processing Equipments水处理设备• Cartridge Filters筒式过滤器• Demineralization Plant脱盐设备• ETP plantETP装置• Submersible Pump潜水泵• UF Water Plant超滤装置• Water Softener Plant软化水装置Other Pharma Equipments其它制药设备• Air Curtain空气帘• Dehumidifier抽湿机• HVAC暖通和空调系统• Laminar Airflow System层流气流系统• Nitrogen Plant制氮装置• Boiler锅炉• Cold Storage冷藏库• Liquid Manufacturing Vessel液体制造容器• Liquid Storage Tank储液槽• Pressure Vessel压力容器• Reactors反应器• Storage Vessel存储容器• Sugar Syrup Manufacturing Tank糖浆制造槽（罐）• WFI Vessel注射用水容器Pharmaceutical Washing Machines制药工业用清洗机• Ampoule Washing Machine安瓿清洗机• Bottle Washing Machine洗瓶机• Bung Washing Machine塞子清洗机• Vial Washing Machine小瓶清洗机Pharma Accessories制药工业用附件• Diaphragm Valve隔膜阀• S.S. Clamp/Triclover Clamp System不锈钢管夹/三管夹。
Q7a（中英文对照）FDA原料药GMP指南Table of Contents 目录1. INTRODUCTION 1. 简介1.1 Objective 1.1目的1.2 Regulatory Applicability 1.2法规的适用性1.3 Scope 1.3范围2. QUALITY MANAGEMENT 2.质量管理2.1 Principles 2.1总则2.2 Responsibilities of the Quality Unit(s) 2.2质量部门的责任2.3 Responsibility for Production Activities 2.3生产作业的职责2.4 Internal Audits (Self Inspection) 2.4内部审计（自检）2.5 Product Quality Review 2.5产品质量审核3. PERSONNEL 3. 人员3.1 Personnel Qualifications 3.人员的资质3.2 Personnel Hygiene 3.2 人员卫生3.3 Consultants 3.3 顾问4. BUILDINGS AND FACILITIES 4. 建筑和设施4.1 Design and Construction 4.1 设计和结构4.2 Utilities 4.2 公用设施4.3 Water 4.3 水4.4 Containment 4.4 限制4.5 Lighting 4.5 照明4.6 Sewage and Refuse 4.6 排污和垃圾4.7 Sanitation and Maintenance 4.7 卫生和保养5. PROCESS EQUIPMENT 5. 工艺设备5.1 Design and Construction 5.1 设计和结构5.2 Equipment Maintenance and Cleaning 5.2 设备保养和清洁5.3 Calibration 5.3 校验5.4 Computerized Systems 5.4 计算机控制系统6. DOCUMENTATION AND RECORDS 6. 文件和记录6.1 Documentation System andSpecifications6.1 文件系统和质量标准6.2 Equipment cleaning and Use Record 6.2 设备的清洁和使用记录6.3 Records of Raw Materials, Intermediates, API Labeling and Packaging Materials 6.3 原料、中间体、原料药的标签和包装材料的记录6.4 Master Production Instructions (MasterProduction and Control Records)6.4 生产工艺规程（主生产和控制记录）6.5 Batch Production Records (BatchProduction and Control Records)6.5 批生产记录（批生产和控制记录）6.6 Laboratory Control Records 6.6 实验室控制记录6.7 Batch Production Record Review 6.7批生产记录审核7. MATERIALS MANAGEMENT 7. 物料管理7.1 General Controls 7.1 控制通则7.2 Receipt and Quarantine 7.2接收和待验7.3 Sampling and Testing of IncomingProduction Materials7.3 进厂物料的取样与测试7.4 Storage 7.4储存7.5 Re-evaluation 7.5复验8. PRODUCTION AND IN-PROCESSCONTROLS8. 生产和过程控制8.1 Production Operations 8.1 生产操作8.2 Time Limits 8.2 时限8.3 In-process Sampling and Controls 8.3 工序取样和控制8.4 Blending Batches of Intermediates orAPIs8.4 中间体或原料药的混批8.5 Contamination Control 8.5 污染控制9. PACKAGING AND IDENTIFICATIONLABELING OF APIs ANDINTERMEDIATES9. 原料药和中间体的包装和贴签9.1 General 9.1 总则9.2 Packaging Materials 9.2 包装材料9.3 Label Issuance and Control 9.3 标签发放与控制9.4 Packaging and Labeling Operations 9.4 包装和贴签操作10. STORAGE AND DISTRIBUTION 10.储存和分发10.1 Warehousing Procedures 10.1 入库程序10.2 Distribution Procedures 10.2 分发程序11. LABORATORY CONTROLS 11.实验室控制11.1 General Controls 11.1 控制通则11.2 Testing of Intermediates and APIs 11.2 中间体和原料药的测试11.3 Validation of Analytical Procedures 11.3 分析方法的验证11.4 Certificates of Analysis 11.4 分析报告单11.5 Stability Monitoring of APIs 11.5 原料药的稳定性监测11.6 Expiry and Retest Dating 11.6 有效期和复验期11.7 Reserve/Retention Samples 11.7 留样12. V ALIDATION 12.验证12.1 Validation Policy 12.1 验证方针12.2 Validation Documentation 12.2 验证文件12.3 Qualification 12.3 确认12.4 Approaches to Process Validation 12.4 工艺验证的方法12.5 Process Validation Program 12.5 工艺验证的程序12.6 Periodic Review of Validated Systems 12.6验证系统的定期审核12.7 Cleaning Validation 12.7 清洗验证12.8 Validation of Analytical Methods 12.8 分析方法的验证13. CHANGE CONTROL 13.变更的控制14. REJECTION AND RE-USE OFMATERIALS14.拒收和物料的再利用14.1 Rejection 14.1 拒收14.2 Reprocessing 14.2 返工14.3 Reworking 14.3 重新加工14.4 Recovery of Materials and Solvents 14.4 物料与溶剂的回收14.5 Returns 14.5 退货15. COMPLAINTS AND RECALLS 15.投诉与召回16. CONTRACT MANUFACTURERS(INCLUDING LABORATORIES)16.协议生产商（包括实验室）17. AGENTS, BROKERS, TRADERS, DISTRIBUTORS, REPACKERS, AND RELABELLERS 17.代理商、经纪人、贸易商、经销商、重新包装者和重新贴签者17.1 Applicability 17.1适用性17.2 Traceability of Distributed APIs andIntermediates17.2已分发的原料药和中间体的可追溯性17.3 Quality Management 17.3质量管理17.4 Repackaging, Relabeling, and Holding of APIs and Intermediates 17.4原料药和中间体的重新包装、重新贴签和待检17.5 Stability 17.5稳定性17.6 Transfer of Information 17.6 信息的传达17.7 Handling of Complaints and Recalls 17.7 投诉和召回的处理17.8 Handling of Returns 17.8 退货的处理18. Specific Guidance for APIs Manufactured by Cell Culture/Fermentation 18. 用细胞繁殖/发酵生产的原料药的特殊指南18.1 General 18.1 总则18.2 Cell Bank Maintenance and RecordKeeping18.2细胞库的维护和记录的保存18.3 Cell Culture/Fermentation 18.3细胞繁殖/发酵18.4 Harvesting, Isolation and Purification 18.4收取、分离和精制18.5 Viral Removal/Inactivation steps 18.5 病毒的去除/灭活步骤19.APIs for Use in Clinical Trials 19.用于临床研究的原料药19.1 General 19.1 总则19.2 Quality 19.2 质量19.3 Equipment and Facilities 19.3 设备和设施19.4 Control of Raw Materials 19.4 原料的控制19.5 Production 19.5 生产19.6 Validation 19.6 验证19.7 Changes 19.7 变更19.8 Laboratory Controls 19.8 实验室控制19.9 Documentation 19.9 文件20. Glossary 20. 术语Q7a GMP Guidance for APIs Q7a原料药的GMP指南1. INTRODUCTION 1. 简介1.1 Objective 1.1目的This document is intended to provide guidance regarding good manufacturing practice (GMP) for the manufacturing of active pharmaceutical ingredients (APIs) under an appropriate system for managing quality. It is also intended to help ensure that APIs meet the quality and purity characteristics that they purport, or are represented, to possess. 本文件旨在为在合适的质量管理体系下制造活性药用成分（以下称原料药）提供有关优良药品生产管理规范（GMP）提供指南。
中华人民共和国卫生部令第 79 号《药品生产质量管理规范（2010年修订）》已于2010年10月19日经卫生部部务会议审议通过，现予以发布，自2011年3月1日起施行。
部长陈竺二○一一年一月十七日第一章总则第一条为规范药品生产质量管理，根据《中华人民共和国药品管理法》、《中华人民共和国药品管理法实施条例》，制定本规范。
第二条企业应当建立药品质量管理体系。
该体系应当涵盖影响药品质量的所有因素，包括确保药品质量符合预定用途的有组织、有计划的全部活动。
第三条本规范作为质量管理体系的一部分，是药品生产管理和质量控制的基本要求，旨在最大限度地降低药品生产过程中污染、交叉污染以及混淆、差错等风险，确保持续稳定地生产出符合预定用途和注册要求的药品。
第四条企业应当严格执行本规范，坚持诚实守信，禁止任何虚假、欺骗行为。
第二章质量管理第一节原则第五条企业应当建立符合药品质量管理要求的质量目标，将药品注册的有关安全、有效和质量可控的所有要求，系统地贯彻到药品生产、控制及产品放行、贮存、发运的全过程中，确保所生产的药品符合预定用途和注册要求。
第六条企业高层管理人员应当确保实现既定的质量目标，不同层次的人员以及供应商、经销商应当共同参与并承担各自的责任。
第七条企业应当配备足够的、符合要求的人员、厂房、设施和设备，为实现质量目标提供必要的条件。
第二节质量保证第八条质量保证是质量管理体系的一部分。
企业必须建立质量保证系统，同时建立完整的文件体系，以保证系统有效运行。
第九条质量保证系统应当确保：（一）药品的设计与研发体现本规范的要求；（二）生产管理和质量控制活动符合本规范的要求；（三）管理职责明确；（四）采购和使用的原辅料和包装材料正确无误；（五）中间产品得到有效控制；（六）确认、验证的实施；（七）严格按照规程进行生产、检查、检验和复核；（八）每批产品经质量受权人批准后方可放行；（九）在贮存、发运和随后的各种操作过程中有保证药品质量的适当措施；（十）按照自检操作规程，定期检查评估质量保证系统的有效性和适用性。
新药研发一、名词解释GMP （Good Manufacturing Practice）药品生产质量管理规范GSP（Good Supply Practice）药品经营质量管理规范GAP（Good Agriculture Practice）良好药材种植规范AMP (Adenosine monophosphate)，腺嘌呤核糖核苷酸cGMP cyclic guanosine monophosphate环磷酸鸟苷GLP Good Laboratory Practice药物非临床研究质量管理规范GCP Good Clinical Practice 药品临床试验管理规范FDA Food and Drug Administration 美国食品药物管理局NDA New Drug Application 新药申请IND Investigational new drug 研发中的新药NAS New active substances 新的活性物质NOSNO nitrogen monoxide一氧化氮CO carbon monoxide一氧化碳Qbd Quality by design 设计决定质量NCE New chemical entities 新化学实体SFDA State Food and Drug Administration国家食品药品监督管理局CDE CENTER FOR DRUG EVALUATION国家食品药品监督管理局药品审评中心CP chinese pharmacopoeia中华人民共和国药典USP United States Pharmacopoeia 美国药典BE bioequivalence 生物等效性BA Bioavailability 生物利用度ADME 吸收（absorption）分布(distribution) 代谢(metabolism) 排泄(excretion) CFR Case report form 病例报告表DMF Drug Master File 药品主文件EDMF European Drug Master File欧盟药品主文件CTD Common Technical Document国际注册用常规技术文件COS（Certificate of Suitability）欧洲药典适应性认证CEP（Certificate of Suitability of Ph Eur）欧洲药典适用性认证Pharmacodynamics（药效学）pharmacokinetics（药动学）adverse reaction（不良反应HTS (High-throughput screening) 高通量筛选药物靶点是指药物在体内的作用结合位点，包括基因位点、受体、酶、离子通道、核酸等生物大分子。
制药行业常用英语词汇中英文对照严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复1、药品生产质量管理规范GMP： Good ManufacturingPractice 2、国家食品与药品监督管理局State Food andDrug Administration3、总则 GeneralProvisions4、《中华人民共和国药品管理法》the DrugAdministration Law of the People's Republic of China 5、制剂 Preparation 6、原料药/原液Drug Substance7、成品 Drug Product8、工艺 process9、机构与人员organization and personnel 10、专业知识professional knowledge严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复11、生产经验production experience 12、组织能力organizational skill 13、技术人员technical staff 14、实施implementation 15、药品生产pharmaceutical manufacturing 16、质量管理quality management 17、质量检验quality inspection 18、专业技术培训professional and technicaltraining 19、基础理论知识basic theoreticalknowledge21、高生物活性 highly potent22、高毒性 high toxicity23、污染 contamination 24、考核评估 assessment 25、厂房与设施 buildings and facilities 26、生产环境 production environment 27、空气洁净级别clean air level 28、昆虫insect29、洁净室(区)clean room(area)30、光滑smooth严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复41、设备 equipment42、物料 material43、中间产品 intermediate product 44、待验品 quarantined material 45、交叉污染cross-contamination 46、管道pipeline, ductwork 47、风口tuber48、公用设施, 公用工程 utilities of publicservice 49、照明 lighting50、照度 illumination31、无裂缝 no cracks 32、无颗粒物脱落 no particle shedding 33、耐受 endure34、消毒 disinfection35、无菌 sterile36、交界处 junction, joint37、弧形 arc38、灰尘积聚 dues accumulation 39、储存区store area 40、生产规模 production scale严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复61、低漏 地漏 floor drainer62、青霉素 penicillin 63、分装室separating room, fillingroom 64、相对负压relative negativepressure 65、废气waste gas,exhausted air 66、 β－ 内酰胺结构类药品 β -Lactasestructure drug, drugs of β- Lactic group67、避孕药品 contraceptives68、激素类 hormone 69、抗肿瘤类anti-tumor, oncology70、放射性药品 Radiopharmaceuticals51、应急 紧急情况 emergency52、净化 purification, clean53、微生物, 微生物学, 微生物的 micro-organism, microbiology,microbiologic 54、监测monitoring 55、记录record56、天棚 天花板ceiling, roof57、密封 seal58、静压差Static DifferentialPressure59、温度 temperature 60、相对湿度RH: Relative Humidity严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复81、预防制品 prevention products82、灌装 filling 83、中药Chinesetraditional medicines84、前处理 pretreatment85、提取 extraction86、浓缩 concentration 87、动物脏器viscera of animal,organ of animal 88、蒸、炒、炙、煅steaming, frying,sunburn, testing 89、炮制 concocted90、通风 ventilation71、包装packing, package 72、循环使用recycling 73、微粒particles 74、辐射radiation, irradiation75、细菌 bacteria76、病毒 virus77、细胞 cell78、脱毒前后pre and post detoxification 79、活疫苗与灭活疫苗active vaccine/inactivatedvaccine 80、人血液制品blood products严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复91、除烟smoke removal 92、除尘dust removal 93、降温设施temperature-reducingestablishment, cooling 94、筛选screening, sift95、切片 slicing 96、粉碎grinding97、压缩空气 compressed air98、惰性气体 noble gas99、取样 Sampling 100、称量室weighing room, dispensingroom 101、中药标本Chinese herbal sample,exemplar ofTCM 102、检定 鉴定 verification, identification103、同位素 Isotope104、设备 equipment 105、选型model/type selection106、耐腐蚀anticorrosion 107、吸附adsorption, absorption 108、润滑剂, 润滑lubricant, lubricate 109、冷却剂 coolant 110、流向 flow direction严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复111、纯化水PW: Purified Water 112、注射用水WFI: Water for Injection 113、滋生 breeding114、储罐 tank115、死角 neglected portion 116、盲管blind pipe 117、纤维fiber118、疏水性hydrophobicity 119、仪表instrumentation 120、量具measuring tool121、衡器 weighing instrument 122、精密度 precision 123、维修、保养 maintenance 124、不合格 disqualified reject 125、物料 material126、购买 purchasing127、发放 releasing128、产地 origin129、入库 loading130、固体 solid严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复141、卫生, 清洁/消毒 sanitation142、车间, 辅房 workshop143、间隔时间 time interval144、清洁剂 detergent145、消毒剂 disinfectant146、废弃物 wastes147、更衣室 changing room148、工作服, work clothes149、颗粒性物质, 颗粒剂 granules150、耐药菌株drug-resistant strain131、液体 liquid132、挥发性 volatile133、净药材 net medicine, netTCM 134、麻醉药品 narcotics135、精神药品 psychotropic drug 136、易燃combustible 137、易爆explosive 138、验收acceptance139、使用说明书instruction 140、标签label严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复161、报废 reject162、 品名 product name163、处方 preion, formula 164、技术参数technicalparameter 165、容器container 166、半成品semi-finished product,intermediate167、申请 application168、稳定性 stability169、起草 draft170、生产管理production management,manufacturing control.151、传染病infectiousdisease 152、皮肤病dermatitis153、验证 verification, validation 154、确认 qualification 155、安装 installation 156、运行running operation 157、性能performance 158、原辅料raw material and incipient 159、文件 document160、投诉 complaint严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复181、产品销售与收回product sales andrecovery /recall 182、投诉与不良反应报告 complaints and adversereaction 183、自检self-inspection 184、附 则schedule appendix 185、平衡balance186、饮用水drinking water, potablewater187、蒸馏法 distillation188、离子交换法 ion exchange 189、反渗透法RO: Reverse Osmosis 190、附加剂添加剂additives171、事故 accident172、混淆 mix-up173、喷雾 spray174、合格证 certificate175、清场 clearance176、质量管理 quality management 177、内控internal control,on-line test 178、滴定液 tartan179、培养基 medium 180、有效期validity, expiry date,shelf life严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复191、滞留stranded resort 192、批batch, lot193、组分, 组成component194、无纤维脱落的过滤器 non-fiber-releasingfilter195、活性成份 Active Ingredient196、非活性成份 Inactive ingredient 197、中间产品in-process product,intermediate product 198、批号batch number 199、药用物料medicated feed 200、药用预混合料medicated premix201、质量控制部门Quality control department 202、理论产量 Theoretical yield203、实际产量 Actual yield204、比率 Percentage, rate205、验收标准可接受标准 Acceptance criteria206、代表性样品 Representative sample207、微粒状的 particulate 208、污染物contaminant 209、石棉asbestos 210、诊断diagnosis严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复221、密封件, 封盖 closure222、效价 Titer223、纯度 purity224、规格 strength225、监督 supervise, monitor226、实验室 laboratory 227、无菌操作aseptic operation,sterile operation 228、层流laminar flow 229、湍流turbulent air flow 230、空气过滤air filtration211、缓解 mitigation212、化学变化 chemical change 213、组分ingredient, component 214、制备fabricate preparation 215、复合 compound216、混合 blend217、加工 processing218、浓度 concentration219、单位剂量 unit dose220、药品包装容器drug product containers严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复241、有机废料organic waste 242、杀鼠剂rodenticides 243、杀昆虫剂insecticides 244、杀真菌剂fungicides 245、熏蒸剂fumigating reagents 246、去垢剂cleaning agents 247、消毒剂sanitizing agents 248、滂沱剂lubricant249、自动化设备、机械化设备和电子设备 automatic, mechanical,or electronic equipment 250、微型胶卷 microfilm231、空气加热 air heating 232、预过滤器 profiler 233、排气系统 exhaust system 234、管件 plumbing 235、虹吸倒流 back-siphon age 236、污水 sewage 237、废料 refuse 238、盥洗设备 toilet facilities 239、空气干燥器 air drier 240、垃圾 trash严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复261、片剂 tablet262、胶囊 capsule263、颗粒剂 granule264、溶解时间 溶出时间 dissolution time 265、澄清度clarity266、隔离系统quarantinesystem, isolation system 267、返工 reprocessing268、发放 issuance, release 269、非处方药OTC:over-the-counter 270、处方药preed medicine251、注射剂 injection252、灭菌设备 sterilization equipment 253、无菌取样技术aseptic sampling techniques 254、显微镜 microscope255、热源, 内毒素 pyrogen, endotoxin256、偏差 deviation257、变更 change control258、进料 charge-in259、项目代码 item code260、鉴别 identify严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复271、皮肤科药、牙粉、胰岛素、喉片 dermatological, dentifrice,insulin, or throat lozenge product 272、保险包装tamper-resistant package273、明胶硬胶囊 hard gelatin capsule274、顺势治疗 homeopathic275、入库 warehousing276、变质 deteriorate277、准确性 accuracy278、灵敏性 sensitivity 279、特异性specificity 280、重复性reproducibility, repeatability281、变应原提取物allergenic extracts 282、眼膏ophthalmic ointment 283、粗糙或磨蚀物质harsh or abrasivesubstances 284、控释制剂controlled-releasedosage form 285、实验动物laboratory animals 286、供应商Supplier 287、光谱spectrum288、测量单位units of measure 289、换算系数conversion factors 290、试剂reagent严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复301、批检验记录BAR: Batch AnalysisRecord 302、工艺规程PP: Process Procedure 303、健康,安全,环保EHS: Environment,Health and Safe 304、美国联邦法规CFR: Code of FederalRegulation 305、美国药典USP: The United StatesPharmacopeia 306、欧洲药典EP: European pharmacopeia 307、英国药典BP: British pharmacopeia 308、药物主文件DMF: Drug Master File 309、验证主计划VMP: Validation MasterPlan 310、验证方案VP: Validation Protocol291、安慰剂 placebo292、明确地 explicitly293、取代 supersede294、溶液 solution 295、批准approval 296、 (美国)食品药品监督管理局 FDA: Food and DrugAdministration 297、标准操作程序SOP: Standard OperatingProcedure 298、质量保证QA: Quality Assurance 299、质量控制QC:Quality Control 300、批生产记录BPR: Batch ProductionRecord 严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复311、验证报告VR: Validation Report 312、安装确认IQ: Installation Qualification 313、运行确认OQ: Operation Qualification 314、性能确认PQ: Performance Qualification 315、超出标准(限度)OOS: Out of Specification 316、冻干产品freeze-dry product,lyophilizated product 317、现场主文件SMF: Site Master File严禁复制复制严禁复制严禁复制严禁复制严禁复制严禁复。
GMP常用名词-中英文对照Lot Number –批号见批号(Batch Number)Manufacture –制造物料的接收、原料药的生产、包装、重新包装、贴签、重新贴签、质量控制、放行、贮存和分发以及相关控制的所有操作。
Material –物料原料(起始物料，试剂，溶剂)，工艺辅助用品，中间体，原料药，和包装及贴签材料的统称。
Mother Liquor –母液结晶或分离后剩下的残留液。
母液可能含有未反应的物料、中间体、不同级别的原料药和/或杂质。
它可用于进一步加工。
Packaging Material –包装材料在储运过程中保护中间体或原料药的任何物料。
Procedure –程序对要进行的操作、要采取的预防措施以及与原料药或中间体生产直接或间接相关的方法的描述文件。
Process Aids –工艺辅料除溶剂外，在原料药或中间体生产中起辅助作用、本身不参与化学或生物学反应的物料(例如，助滤剂、活性炭)。
Process Control –工艺控制见中间控制在原料药制备过程中，从接收原料，到工艺加工和原料药包装所涉及的所有操作。
Qualification –确认证明设备或辅助系统，安装正确、工作正常、确实产生预期的结果，并以文件佐证的行为。
确认是验证的一部分，但单独的确认步骤不构成工艺验证。
Quality Assurance (QA) –质量保证以确保所有原料药达到其应用所要求的质量，并维持质量体系为目的的全部组织安排的总和。
Quality Control –质量控制是否符合质量规格的检查或测试。
Quality Unit(s) –质量部门独立于生产部门的履行质量保证和质量控制职责的组织机构。
按照组织机构的大小和结构，可以是单独的QA 和QC部门，或个人，或小组。
Quarantine –待验在实物上或以其它有效方式将物料隔离，等待对其随后的批准或拒收做出决定的状态。
Raw Material –原料用来表示中间体或原料药的生产中要用的起始物料、试剂和溶剂的通用专业名词。
GMP中英文对照GMP相关的英文缩写1. AQAI(Automated Quality Assurance Inspection Equipment):在线自动质量保证检查设备.2. API(Active Pharmaceutical Ingredient):活性药物物质,即原料药.3. ANDA (Abbreviated New Drug Application):简化新药申请.4. ADR(Adverse Drug Reaction):不良反应.5. BSE(Bovine Spongiform Encephalopathy):疯牛病.6. BPCS(Business Planning and Control System):业务计划及控制系统.7. BIA(Business impact assessment): 商业影响评估.8. cGMP(current Good Manufacturing Practice):现行药品生产质量管理规范.9. CCCD(China Certification Committee for Drugs):中国药品认证委员会.10. CIP(Cleaning In Place):在线清洁. 11. CV(Concurrent Validation):同步验证.12. CDER( Center for Drug Evaluation and Research): 药品研究与评价中心.13. COA(Certificate Of Analysis):分析报告单.14. CFR(Code of Federal Regulation):(美国)联邦法规.15. CDC(Centers for Disease Control and Prevention):疾病预防控制中心.16. COS / CEP( Certificate of Suitability for European Pharmacopeia ):欧洲药典适用性证书.17. CCD (Certification Committee for Drugs):药品认证管理中心. 18. CPMP(Committee for Proprietary Medicinal Products): 欧洲专利药品委员会.19. CTD(Common Technical Document):通用技术文件.20. CDC( Centers for Disease Control and Prevention): 疾病预防控制中心.21. GMP(Good Manufacturing Practice):药品生产质量管理规范. 22. ICH(International Conference on Harmonization of Technical Requ irements for Registration of Pharmaceuticals for Human Use):人用药品注册技术要求国际协调会. 23. EU(European Union):欧洲联盟.24. EFPIA(European Federation of Pharmaceutical Industries Associations ):欧洲制药工业协会联合会.25. MHW(Ministry of Health and Welfare,Japan):日本厚生省.26. JPMA(Japan Pharmaceutical Manufacturers Association):日本制药工业协会.27. FDA(US Food and Drug Adminiistration):美国食品与药品管理局.28. PRMA(Pharmaceutical Research and Manufacturers of America):美国药物研究和生产联合会.29. WHO(World Health Organization):世界卫生组织.30. IFPMA(International Federation of Pharmaceutical Manufacturers As sociations):国际制药工业协会联合会.31. TQC(Total Quality Control),TQM(Total Quality Management): 全面质量管理.32. PDCA(Plan,Do,Check,Action):计划,执行,检查,处理.33. QA(Quality Assurance):质量保证.34. QC (Quality Control):质量控制.35. QS(Quality System):质量体系.36. QM(Quality Management): 质量管理.37. SOP(Standard Operating Procedure): 标准操作规程.38. SMP(Standard Management Procedure):标准管理程序.39. SOR(Standard Operating Record): 标准操作记录.40. GEP(Good Engineering Practice):工程设计规范.41. HVAC(Heating Ventilation and Air Conditioning):空调净化系统.42. DQ(Design Qualification):设计确认.43. IQ(Installation Qualification):安装确认.44. OQ(Operational Qualification):运行确认.45. PQ(Performance Qualification):性能确认.46. OOS(Out-Of-Specification):检验不合格;超标.47. PFDS(Process Flow Diagrams):工艺流程图.48. MRA(cMutual Reognition Agreements): 现场检查多边认同协议.49. DMF( Drug Master File):药物主文件.50. EDMF(European Drug Master File)欧盟药物主文件.51. EDQM（European Directorate for Quality Medicines）: 欧洲药品质量管理局.52. ORA(Office of Regulatory Affairs):药政事务办公室.53. GGPs( Good Guidance Practices): 优良指南规范.54. MOA(Method Of Analysis):分析方法.55. VMP(Validation Master Plan):验证主计划.56. VP(Validation Protocol):验证方案.57. MSDS(Material Safety Data Sheet):物料安全技术说明书.58. NDA (New Drug Application):新药申请.59. OTC(Over-the-counter):非处方.60. INN(International Nonproprietary Name):国际非专有名称.61. USP(the united state pharmacopeia): 美国药典.62. NF(National Formulary):(美国)国家药品集.63. GAP(Good Agricultural Practice):中药材种植管理规范.64. GCP(Good Clinical Practice):药物临床试验质量管理规范.65. GLP(Good Laboratory Practice):药物实验室管理规范.66. GSP(Good Supply Practice):药品经营质量管理规范.67. GUP(Good Use Practice):药品使用质量管理规范.68. SM(Starting Material):起始物料.69. PMF(Plant Master File); SMF(Site Master File):工厂主文件.70. EDL(List of Essential Drugs ) : 基本药物目录.71. PI(Package Insert):说明书.72. PCT( Patent Cooperation Treaty): 专利合作条约.73. PPAC(Patent Protection Association of China):中国专利保护协会.74. PIC( Person In Charge) :负责人.75. PDS(Pharmaceutical Development Services): 整体新药研发机构.76. SPC(Summary of Product Characteristics):产品特性摘要.。
GMP词汇一更衣室 Changing Room一更 First Changing Room手消室 Hands Disinfection Room气闸室 Airlock Room洁具室 Cleaning Tools Room清洗室 Cleaning Room模具室 Dies Room内包装室Immediate Package Room安全门 Emergency Door外包清室Outer Package Removing Room 存料间 Storage Room of Raw Materials 粉碎室 Pulverizing Room备料室 Materials Preparing Room硬胶室 Hard Capsules Filling Room软胶室 Soft Capsules Room制粒干燥室 Granulating and Drying Room 总混间 Blending Room中间站 Intermediate Station压片室 Tablets Room Compression Room 包衣室 Coating Room配浆间 Coating Mixture Preparing Room 铝塑包装间 Packing Room传递窗 Transferring Window外包装室Outer Packing Room蒸馏水室Water Purifying Room质检室 Quality Control Room浓配室 Concentrated Solution Room稀配室 Diluted Solution Room BATCH PRODUCTION：批量生产；分批生产BATCH PRODUCTION RECORDS：生产批号记录POST-OR PRE- MARKET SURVEILLANCE：销售前或销售后监督INFORMED CONSENT：知情同意（患者对治疗或受试者对医疗试验了解后表示同意接受治疗或试验）PRESCRIPTION DRUG：处方药OTC DRUG（OVER—THE—COUNTER DRUG）：非处方药U．S．PUBLIC HEALTH SERVICE：美国卫生福利部药品制备preparation of drug products针对 pertain to人用生物制品 biological products for human use补充 supplement代替条例supersede the requlation提议免除proposed exemption一般销售和消费 ordinarily marketed and consumed美德，优点，效力 virtue联邦注册表 FR/federal register人用物品 human foods用于鉴别，测定 shall be applied in determining生产，加工，包装，贮存 manufacture,process,pack,hold,职责和权力responsibility and authority批准和拒收 approve or reject/withhold复查生产记录review production records对qc来说可以获得的shall be available to QC适当的 adequate效价和含量 strength提供证明文件 shall be documented符合 conform to制订完善 sound每装货量 each shipment变质的is subject to deteriorationaccommodation (车，船，飞机等的)预定铺位批号 batch有害微生物 objectionable microorganism联合批号 the number of units准确性，灵敏性，特异性，重复性accuracy, sensitivity, specificity, and reproducibility特征，属性attribute配伍reconstitution设计 project顺势治疗药品 homeopathic drug products可配伍性compatibility标明 purporting to应成文并遵循shall be in writing and shall be followed.可检出水平 detectable levels通过参考文献具体化 incorporated by reference副作用 adeverse/side effect类型 type混放 mixups签收 receipt处理 disposition正压下过滤 be filtered under positive pressure层流或非层流laminar or nonlaminar;无菌环境aseptic conditions照明 lighting通风、空气过滤、空气加热与冷却 Ventilation, air filtration, air heating and cooling.空气输送系统 Air-handling systems附近建筑物immediate premises专用毛巾 single-service towels 进料 Charge-in标示量或规定量labeled or established amount实际产量 Actual yields理论产量 theoretical yields生产周期 the production of a batch of a drug product药品的一致性和完整性uniformity and integrity of drug products崩解时间 Disintegration time溶液的澄明度、溶解完全性及pH值 Clarity, completeness, or pH of solutions稳定性评估 variability estimates装卸 handlingNIH（NATIONAL INSTITUTE OF HEALTH）：（美国）全国卫生研究所CLINICAL TRIAL：临床试验ANIMAL TRIAL：动物试验ACCELERATED APPROVAL：加速批准FDA（FOOD AND DRUG ADMINISTRATION）：（美国）食品药品管理局IND（INVESTIGATIONAL NEW DRUG）：临床研究申请（指申报阶段，相对于NDA而言）；研究中的新药（指新药开发阶段，相对于新药而言，即临床前研究结束）NDA（NEW DRUG APPLICATION）：新药申请ANDA（ABBREVIATED NEW DRUG APPLICATION）：简化新药申请EP诉（EXPORT APPLICATION ）：出口药申请（申请出口不被批准在美国销售的药品）TREATMENT IND：研究中的新药用于治疗ABBREVIATED（NEW）DRUG：简化申请的新药DMF（DRUG MASTER FILE）：药物主文件（持有者为谨慎起见而准备的保密资料，可以包括一个或多个人用药物在制备、加工、包装和贮存过程中所及的设备、生产过程或物品。
[SCHEDULE M][See Rules 71, 74, 76 and 78]GOOD MANUFACTURING PRACTICES AND REQUIREMENTS OF PREMISES,PLANT AND EQUIPMENT FOR PHARMACEUTICAL PRODUCTS.Note: - To achieve the objectives listed below, each licensee shall evolve appropriate methodology, systems and procedures which shall be documented and maintained for inspection and reference; and the manufacturing premises shall be used exclusively for production of drugs and no other manufacturing activity shall be undertaken therein.PART 1GOOD MANUFACTURING PRACTICES FOR PREMISES AND MATERIALS. 1. GENERAL REQUIREMENTS1.1. Location and surroundings.- The factory building(s) for manufacture of drugs shall be so situated and shall have such measures as to avoid risk of contamination from external environmental including open sewage, drain, public lavatory or any factory which product disagreeable or obnoxious odour, fumes, excessive soot, dust, smoke, chemical or biological emissions.1.2. Building and premises.- The building(s) used for the factory shall be designed, constructed, adapted and maintained to suit the manufacturing operations so as to permit production of drugs under hygienic conditions. They shall conform to the conditions laid down in the Factories Act, 1948 (63 of 1948)The premises used for manufacturing, processing, warehousing, packaging labeling and testing purposes shall be ._____________________________________________________________________ ●Omitted by G.O.I.Notification No.G.S.R.462(E) dt.22.06.1982.●●Ins.by G.O.I.Notification NoG.S.R.864(E) dt.11.12.2001.- applicable to manufacturers licensed to manufacture drugs, for the period upto 31.12.2003.(i) compatible with other drug manufacturing operations that may be carriedout in the same or adjacent area / section;(ii) adequately provided with working space to allow orderly and logicalplacement of equipment, materials and movement of personnel so as to:(a) avoid the risk of mix-up between different categories of drugs orwith raw materials, intermediates and in-process material;(b) avoid the possibilities of contamination and cross- contaminationby providing suitable mechanism;(iii) designed / constructed / maintained to prevent entry of insects, pests,birds, vermins, and rodents. Interior surface (walls, floors and ceilings)shall be smooth and free from cracks, and permit easy cleaning, paintingand disinfection;(iv) air-conditioned, where prescribed for the operations and dosage fromsunder production. The production and dispensing areas shall be welllighted, effectively ventilated, with air control facilities and may haveproper Air Handling Units (wherever applicable) to maintain conditionsincluding temperature and, wherever necessary, humidity, as defined forthe relevant product. These conditions shall be appropriate to the categoryof drugs and nature of the operation. These shall also be suitable to thecomforts of the personnel working with protective clothing, productshandled, operations undertaken within them in relation to the external environment. These areas shall be regularly monitored for compliancewith required specifications;(v) Provided with drainage system, as specified for the various categories of products, which shall be of adequate size and so designed as to preventback flow and/or prevent insets and rodents entering the premises. Openchannels shall be avoided in manufacturing areas and, where provided,these shall be shallow to facilitate cleaning and disinfection;(vi) The walls and floors of the areas where manufacture of drugs is carriedout shall be free from cracks and open joints to avoid accumulation ofdust. These shall be smooth, washable, covered and shall permit easy andeffective cleaning and dis-infection. The interior surfaces shall not shedparticles. A periodical record of cleaning and painting of the premisesshall be maintained.1.3 Water System. - There shall be validated system for treatment of waterdrawn from own or any other source to render it potable in accordance with standards specified by the Bureau of Indian Standards or Local Municipality, as the case may be, soas to produce Purified Water conforming to Pharmacopoeial specification. Purified Waterso produced shall only be used for all operations except washing and cleaning operationswhere potable water may be used. Water shall be stored in tanks, which do not adverselyaffect quality of water and ensure freedom from microbiological growth. The tank shallbe cleaned periodically and records maintained by the licensee in this behalf.1.4. Disposal of waste. –(i) The disposal of sewage and effluents (solid, liquid and gas) fromthe manufactory shall be in conformity with the requirements ofEnvironment Pollution Control Board.(ii) All bio-medical waste shall be destroyed as per the provisions ofthe Bio-Medical Waste (Management and Handling) Rules, 1996.(iii) Additional precautions shall be taken for the storage and disposalof rejected drugs. Records shall be maintained for all disposal ofwaste.(iv) Provisions shall be made for the proper and safe storage of wastematerials awaiting disposal. Hazardous,toxic substances andflammable materials shall be stored in suitably designed andsegregated, enclosed areas in conformity with Central and StateLegislations.2. Warehousing Area. -2.1 Adequate areas shall be designed to allow sufficient and orderlywarehousing of various categories of materials and products like starting and packaging materials, intermediates, bulk and finished products, products in quarantine, released,rejected, returned or recalled, machine and equipment spare parts and change items.2.2 Warehousing areas shall be designed and adapted to ensure good storage conditions. They shall be clean, dry and maintained with acceptable temperature limits,where special storage conditions are required (e.g. temperature, humidity), these shall be provided, monitored and recorded. Storage areas shall have appropriate house-keeping and rodent, pests and vermin control procedures and records maintained. Proper racks,bins and platforms shall be provided for the storage of materials.2.3 Receiving and dispatch bays shall protect materials and products fromadverse weather conditions.2.4. Where quarantine status is ensured by warehousing in separate earmarkedareas in the same warehouse or store, these areas shall be clearly demarcated. Any system replacing the physical quarantine, shall give equivalent assurance of segregation. Access to these areas shall be restricted to authorized persons.2.5. There shall be a separate sampling area in the warehousing area for activeraw materials and excipients. If sampling is performed in any other area, it shall be conducted in such a way as to prevent contamination, cross-contamination and mix-up.2.6. Segregation shall be provided for the storage of rejected, recalled orreturned materials or products. Such areas, materials or products shall be suitably marked and secured. Access to these areas and materials shall be restricted.2.7. Highly hazardous, poisonous and explosive materials such as narcotics, psychotropic drugs and substances presenting potential risks of abuse, fire or explosion shall be stored in safe and secure areas. Adequate fire protection measures shall be provided in conformity with the rules of the concerned civic authority.2.8. Printed packaging materials shall be stored in safe, separate and secureareas.2.9. Separate dispensing areas for β(Beta) lactum, Sex Hormones andCytotoxic substances or any such special categories of product shall be provided with proper supply of filtered air and suitable measures for dust control to avoid contamination. Such areas shall be under differential pressure.2.10. Sampling and dispensing of sterile materials shall be conducted underaseptic conditions conforming to Grade A, which can also be performed in a dedicated area within the manufacturing facility.2.11. Regular checks shall be made to ensure adequate steps are taken against spillage, breakage and leakage of containers.2.12. Rodent treatments (Pest control) should be done regularly and at leastonce in a year and record maintained.3. Production area. -3.1. The production area shall be designed to allow the production preferablyin uni-flow and with logical sequence of operations.3.2. In order to avoid the risk of corss-contamination, separate dedicated andself-contained facilities shall be made available for the production of sensitive pharmaceutical products like penicillin or biological preparations with live microorganisms.Separate dedicated facilities shall be provided for the manufacture of contamination causing and potent products such as Beta-Lactum, sex hormones and cytotoxic substances.3.3. Working and in-process space shall be adequate to permit orderly andlogical positioning of equipment and materials and movement of personnel to avoid cross-contamination and to minimize risk of omission or wrong application of any manufacturing and control measures.3.4. Pipe-work, electrical fittings, ventilation openings and similar serviceslines shall be designed, fixed and constructed to avoid creation of recesses. Services lines shall preferably be identified by colours and the nature of the supply and direction of the flow shall be marked/indicated.4. Ancillary Areas. –4.1 Rest and refreshment rooms shall be separate from other areas. Theseareas shall not lead directly to the manufacturing and storage areas.4.2 Facilities for changing, storing clothes and for washing and toilet purposesshall be easily accessible and adequate for the number of users. Toilets, separate for males and females, shall not be directly connected with production or storage areas. There shall be written instructions for cleaning and disinfection of such areas.4.3 Maintenance workshops shall be separate and away from production areas. Whenever spares, changed parts and tools are stored in the production area, these shall be kept in dedicated rooms or lockers. Tools and spare parts for use in sterile areas shall be disinfected before these are carried inside the production areas.4.4. Areas housing animals shall be isolated from other areas. The other requirements regarding animal houses shall be those as prescribed in Rule 150-C(3) of the Drugs and Cosmetics Rules, 1945 which shall be adopted for production purposes.5. Quality Control Area.-5.1. Quality Control Laboratories shall be independent of the production areas. Separate areas shall be provided each for physico-chemical, biological, microbiological or radio-isotope analysis. Separate instrument room with adequate area shall be provided for sensitive and sophisticated instruments employed for analysis.5.2 Quality Control Laboratories shall be designed appropriately for theoperations to be carried out in them. Adequate space shall be provided to avoid mix-ups and cross-contamination. Sufficient and suitable storage space shall be provided for test samples, retained samples, reference standards, reagents and records.5.3. The design of the laboratory shall take into account the suitability of construction materials and ventilation. Separate air handling units and otherrequirements shall be provided for biological, microbiological and radioisotopes testing areas. The laboratory shall be provided with regular supply of water of appropriate quality for cleaning and testing purpose.5.4. Quality Control Laboratory shall be divided into separate sections i.e. for chemical, microbiological and wherever required, biological testing. These shall have adequate area for basis installation and for ancillary purposes. The microbiology section shall have arrangements such as airlocks and laminar air flow work station, wherever considered necessary.6. Personnel.-6.1. The manufacture shall be conducted under the direct supervision ofcompetent technical staff with prescribed qualifications and practical experience in the relevant dosage and / or active pharmaceutical products.6.2 The head of the Quality Control Laboratory shall be independent of the manufacturing unit. The testing shall be conducted under the direct supervision of competent technical staff who shall be whole time employees of the licensee.6.3. Personnel for Quality Assurance and Quality Control operations shall be suitably qualified and experienced.6.4. Written duties of technical and Quality Control personnel shall be laid and following strictly.6.5. Number of personnel employed shall be adequate and in direct proportionto the workload.6.6. The licensee shall ensure in accordance with a written instruction that all personnel in production area or into Quality Control Laboratories shall receive training appropriate to the duties and responsibility assigned to them. They shall be provided with regular in-service training.7. Health, clothing and sanitation of workers. -7.1 The personnel handling Beta-lactum antibiotics shall be tested forPenicillin sensitivity before employment and those handling sex hormones, cytotoxic substances and other potent drugs shall be periodically examined for adverse effects. These personnel should be moved out of these sections (except in dedicated facilities), by rotation, as a health safeguard.7.2 Prior to employment, all personnel, shall undergo medical examination including eye examination, and shall be free from Tuberculosis, skin and other communicable or contagious diseases. Thereafter, they should be medically examined periodically, at least once a year. Records shall be maintained thereof. The licensee shall provide the services of a qualified physician for assessing the health status of personnel involved in different activities.7.3 All persons prior to and during employment shall be trained in practiceswhich ensure personnel hygiene. A high level of personal hygiene shall be observed by all those engaged in the manufacturing processes. Instructions to this effect shall be displayed in change rooms and other strategic locations.7.4 No person showing, at any time, apparent illness or open lesions whichmay adversely affect the quality of products, shall be allowed to handle starting materials,packing materials, in-process materials, and drug products until hiscondition is no longer judged to be a risk.7.5 All employees shall be instructed to report about their illness or abnormalhealth condition to their immediate supervisor so that appropriate action can be taken.7.6 Direct contact shall be avoided between the unprotected hands ofpersonnel and raw materials, intermediate or finished, unpacked products.7.7 All personnel shall wear clean body coverings appropriate to their duties.Before entry into the manufacturing area, there shall be change rooms separate for each sex with adequate facilities for personal cleanliness such as wash basin with running water, clean towels, hand dryers, soaps, disinfectants, etc. The change room shall be provided with cabinets for the storage of personal belongings of the personnel.7.8 Smoking, eating, drinking, chewing or keeping plants, food, drink andpersonal medicines shall not be permitted in production, laboratory, storage and other areas where they might adversely influence the product quality.8. Manufacturing Operations and Controls. -8.1 All manufacturing operations shall be carried out under the supervision of technical staff approved by the Licensing Authority. Each critical step in the process relating to the selection, weighing and measuring of raw material addition during various stages shall be performed by trained personnel under the direct personal supervision of approved technical staff.The contents of all vessels and containers used in manufacture and storage during the various manufacturing stages shall be conspicuously labeled with the name of the product, batch number, batch size and stage of manufacture. Each label should be initialled and dated by the auhorised technical staff.Products not prepared under aseptic conditions are required to be free from pathogens like Salmonella, Escherichia coli, Pyocyanea, etc.8.2. Precautions against mix-up and cross-contamination-8.2.1. The licensee shall prevent mix-up and cross-contamination of drugmaterial and drug product (from environmental dust) by proper air-handling system, pressure differential, segregation, status labeling and cleaning. Proper records and Standard Operating Procedures thereof shall be maintained.8.2.2 The licensee shall ensure processing of sensitive drugs like Beta-Lactum antibiotics, sex hormones and cytotoxic substances in segregated areas or isolated production areas within the building with independent air-handling unit and proper pressure differential. The effective segregation of these areas shall be demonstrated with adequate records of maintenance and services.8.2.3 To prevent mix-ups during production stages, materials under processshall be conspicuously labeled to demonstrate their status. All equipment used for production shall be labeled with their current status.8.2.4 Packaging lines shall be independent and adequately segregated. It shallbe ensured tat all left-overs of the previous packaging operations, including labels, cartons and caps are cleared before the closing hour.8.2.5 Before packaging operations are begun, steps shall be taken to ensure thatthe work area, packaging lines, printing machines, and other equipment are clean andfree from any products, materials and spillages. The line clearance shall be performed according to an approximate check-list and recorded.8.2.6 The correct details of any printing (for example of batch numbers orexpiry dates) done separately or in the course of the packaging shall be rechecked at regular intervals. All printing and overprinting shall be authorized in writing.8.2.7 The manufacturing environment shall be maintained at the required levelsof temperature, humidity and cleanliness.8.2.8 Authorised persons shall ensure change-over into specific uniforms before undertaking any manufacturing operations including packaging.8.2.9 There shall be segregated enclosed areas, secured for recalled or rejected material and for such materials which are to e reprocessed or recovered.9. Sanitation in the Manufacturing Premises. -9.1 The manufacturing premises shall be cleaned and maintained in an orderly manner, so that it is free from accumulated waste, dust, debris and other similar material. A validated cleaning procedure shall be maintained.9.2 The manufacturing areas shall not be used for storage of materials, exceptfor the material being processed. It shall not be used as a general throughfare.9.3 A routine sanitation program shall be drawn up and observed, which shallbe properly recorded and which shall indicate--(a) specific areas to be cleaned and cleaning intervals;(b) cleaning procedure to be followed, including equipment and materialsto be used for cleaning; and(c) personnel assigned to and responsible for the cleaning operation.9.4 The adequacy of the working and in-process storage space shall permit the orderly and logical positioning of equipment and materials so as to minimize the risk of mix-up between different pharmaceutical products or their components to avoid cross contamination, and to minimise the risk of omission or wrong application of any of the manufacturing or control steps.9.5 Production areas shall be well lit, particularly where visual on-linecontrols are carried out.10. Raw Materials. -10.1 The licensee shall keep an inventory of all raw materials to be used at anystage of manufacture of drugs and maintain records as per Schedule U.10.2 All incoming materials shall be quarantined immediately after receipt or processing. All materials shall be stored under appropriate conditions and in an orderly fashion to permit batch segregation and stock rotation by a”first in/first expiry”-”first-out”principle. All incoming materials shall be checked to ensure that the consignment corresponds to the order placed.10.3 All incoming materials shall be purchased from approved sources undervalid purchase vouchers. Wherever possible, raw materials should be purchased directly from the producers.10.4 Authorized staff appointed by the licensee in this behalf, which mayinclude personnel from the Quality Control Department, shall examine each consignment on receipt and shall check each container for integrity of package andseal. Damaged containers shall be identified, recorded and segregated.10.5 If a single delivery of material is made up of different batches, each batchshall be considered as a separate batch for sampling, testing and release.10.6 Raw materials in the storage area shall be appropriately labeled. Labelsshall be clearly marked with the following information:(a) designated name of the product and the internal code reference, where applicable, and analytical reference number;(b) manufacturer.s name, address and batch number;(c) the status of the contents (e.g. quarantine, under test, released,approved, rejected); and(d) the manufacturing date, expiry date and re-test date.10.7 There shall be adequate separate areas for materials .under test.,.approved. and .rejected. with arrangements and equipment to allow dry, clean and orderly placement of stored materials and products, wherever necessary, under controlled temperature and humidity.10.8 Containers from which samples have been drawn shall be identified.10.9 Only raw materials which have been released by the Quality Control Department and which are within their shelf-life shall be used. It shall be ensured that shelf life of formulation product shall not exceed with that of active raw materials used.10.10 It shall be ensured that all the containers of raw materials are placed on the raised platforms/racks and not placed directly on the floor.11. Equipment. -11.1 Equipment shall be located, designed, constructed, adapted andmaintained to suit the operations to be carried out. The layout and design of the equipment shall aim to minimise the risk of errors and permit effective cleaning and maintenance in order to avoid cross-contamination, build-up of dust or dirt and, in general any adverse effect on the quality of products. Each equipment shall be provided with a logbook, wherever necessary.11.2 Balances and other measuring equipment of an appropriate range,accuracy and precision shall be available in the raw material stores, production and in process control operations and these shall be calibrated and checked on a scheduled basis in accordance with Standard Operating Procedures and records maintained. 11.3 The parts of the production equipment that come into contact with theproduct shall not be reactive, additive or adsorptive to an extent that would affect the quality of the product.11.4 To avoid accidental contamination, wherever possible, non-toxic/ediblegrade lubricants shall be used and the equipment shall be maintained in a way that lubricants do not contaminate the products being produced.11.5 Defective equipment shall be removed from production and QualityControl areas or appropriately labeled.12. Documentation and Records. - Documentation is an essential part of the Quality assurance system and, as such, shall be related to all aspects Good Manufacturing Practices (GMP). Its aim is to define the specifications for all materials, method ofmanufacture and control, to ensure that all personnel concerned with manufacture know the information necessary to decide whether or not to release a bath of drug for sale and to provide an audit trail that shall permit investigation of the history of any suspected defective batch.12.1 Documents designed, prepared, reviewed and controlled, wherever applicable, shall comply with these rules.12.2 Documents shall be approved, signed and dated by appropriate andauthorized persons.12.3 Documents shall specify the title, nature and purpose. They shall be laidout in an orderly fashion and be easy to check. Reproduced documents shall be clear and legible. Documents shall be regularly reviewed and kept up to date. Any alteration made in the entry of a document shall be signed and dated.12.4 The records shall be made or completed at the time of each operation insuch a way that all significant activities concerning the manufacture of pharmaceutical products are traceable. Records and associated Standard Operating Procedures (SOP) shall be retained for at least one year after the expiry date of the finished product.12.5 Data may be recorded by electronic data processing systems or otherreliable means, but Master Formulae and detailed operating procedures relating to the system in use shall also be available in a hard copy to facilitate checking of the accuracy of the records. Wherever documentation is handled by electronic data processing methods, authorized persons shall enter modify data in the computer. There shall be record of changed and deletions. Access shall be restricted by .passwords. or other means and the result of entry of critical data shall be independently checked. Batch records electronically stored shall be protected by a suitable back-up. During the period of retention, all relevant data shall be readily available.13. Labels and other Printed Materials. - Labels are absolutely necessary for identification of the drugs and their use. The Printing shall be done in bright colours and in a legible manner. The label shall carry all the prescribed details about the product.13.1 All containers and equipment shall bear appropriate labels. Differentcolour coded tablets shall be used to indicate the status of a product (for example under test, approved, passed, rejected).13.2 To avoid chance mix-up of printed packaging materials, product leaflets, relating to different products, shall be stored separately.13.3 Prior to release, all labels for containers, cartons and boxes and allcirculars, inserts and leaflets shall be examined by the Quality Control Department of the licensee.13.4 Prior to packaging and labeling of a given batch of a drug, it shall beensured by the licensee that samples are drawn from the bulk and duly tested, approved and released y the quality control personnel.13.5 Records of receipt of all labeling and packaging materials shall bemaintained for each shipment received indicating receipt, control reference numbersand whether accepted or rejected. Unused coded and damaged labels and packaging materials shall be destroyed and recorded.13.6 The label or accompanying document of reference standards and reference culture shall indicate concentration, lot number, potency, date on which containers was first opened and storage conditions, where appropriate.14. Quality Assurance. - This is a wide-ranging concept concerning allmatters that individually or collectively influence the quality of a product. It is the totality of the arrangements made with the object of ensuring that products are of the quality required for their intended use.14.1 The system of quality assurance appropriate to the manufacture of pharmaceutical products shall ensure that: -(a) the pharmaceutical products are designed and developed in a way that takes account of the requirement of Good Manufacturing Practices (herein referred as GMP) and other associated codes such as those of Good Laboratory Practices (hereinafter referred as GLP) and Good Clinical Practices (herein after referred as GCP);(b) adequate arrangements are made for manufacture, supply and use of the correct starting and packaging materials.(c) adequate controls on starting materials, intermediate products, and bulk products and other in-process controls, calibrations, and validations are carried out.(d) the finished product is correctly processed and checked in accordance with established procedures;(e) the pharmaceutical products are not released for sale or supplied before authorized persons have certified that each production batch as been produced and controlled in accordance with the requirements of the label claim and any other provisions relevant to production, control and release of pharmaceutical products.15. Self Inspection and Quality audit - It may be useful to constitute a selfinspection team supplemented with a quality audit procedure for assessment of all or part of a system with the specific purpose of improving it.15.1 To evaluate the manufacturer.s compliance with GMP in all aspects of production and quality control, concept of self-inspection shall be followed. The manufacturer shall constitute a team of independent, experienced, qualified persons from within or outside the company, who can audit objectively the implementation of methodology and procedures evolved. The procedure for self-inspection shall be documented indicating self-inspection results; evaluation, conclusions and recommended corrective actions with effective follow up program. The recommendations for corrective action shall be adopted.15.2 The program shall be designed to detect shortcomings in theimplementation of Good Manufacturing Practice and to recommend the necessary corrective actions. Self-inspections shall be performed routinely and on specific occasions, like when product recalls or repeated rejections occur or when an inspection by the licensing authorities is announced. The team responsible for self-inspection shall consist of personnel who can evaluate the implementation of Good Manufacturing Practice objectively; all recommendations for corrective action shall be implemented.。
